Yael L. Maxwell's profile photo

Yael L. Maxwell

Senior Medical Journalist at TCTMD

Senior Medical Journalist @TCTMD & #FellowsForum Section Editor. Mama to 2 tiny humans. Student of the world. All tweets my own. @yaelmaxwell.bsky.social

Featured in: Favicon tctmd.com Favicon mentalfloss.com Favicon refinery29.com Favicon newsbreak.com Favicon acponline.org Favicon octnews.org Favicon ourcommunitynow.com Favicon citylifestyle.com Favicon acphospitalist.acponline.org

Articles

  • Rising Cardiac Mortality Since the COVID Era Raises Questions About Healthcare Delivery

    3 weeks ago | tctmd.com | Yael L. Maxwell

    With new CVD treatments arriving each year, “there’s no reason why outcomes should be getting worse,” says Jason Wasfy. Cardiac mortality rates have increased in Massachusetts annually since the start of the COVID-19 pandemic in 2020, with exaggerated seasonal patterns and upticks in at-home deaths, according to new population-based data.

  • Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

    3 weeks ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 The results suggest potential harm when leaving patients who’ve received ultrathin-strut stents on DAPT beyond 1 year. PARIS, France—Three-year findings from the HOST-IDEA trial continue to support a strategy of shorter-duration dual antiplatelet therapy (DAPT) following PCI with contemporary, ultrathin-strut drug-eluting stents.

  • FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

    4 weeks ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 Researchers say the data further support the use of an FFR-first strategy in treating intermediate coronary lesions. PARIS, France—Even several years after intervention, fractional flow reserve (FFR)-guided PCI remains as safe and effective as IVUS-guided PCI when it comes to managing intermediate coronary lesions, according to extended follow-up from the FLAVOUR trial presented at EuroPCR 2025.

  • Early Coronary Function Testing Improves Quality of Life in ANOCA

    1 month ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 In the ILIAS ANOCA trial, using CFT to guide treatment according to ANOCA endotype led to larger QoL gains over 6 months.

  • Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

    1 month ago | tctmd.com | Yael L. Maxwell

    News Conference News EuroPCR 2025 As patients experience all events, not just the first, researchers should consider adjusting their trials to capture all outcomes. PARIS, France—One month of dual antiplatelet therapy (DAPT) after PCI using contemporary stents not only is associated with similar rates of adverse clinical outcomes compared with 3 months or more in patients at high bleeding risk, but also lowers the total number of events, according to new data from MASTER DAPT.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
4K
Tweets
6K
DMs Open
No
Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
9 Jun 25

Dimitrios Karmpaliotis, MD, PhD, an interventional cardiologist known for his expertise in the field of complex PCI, died suddenly at home yesterday at age 53. News of his death was confirmed by colleagues today. https://t.co/8kmoHRjCGC

Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
6 Jun 25

RT @EuroInterventio: 🎥@DFCapodanno shares how his role as Editor-in-Chief at EuroIntervention allows him to give back to the cardiology com…

Yael L. Maxwell
Yael L. Maxwell @TCTMD_Yael
4 Jun 25

Cardiac mortality rates have increased in Massachusetts annually since the start of the COVID-19 pandemic in 2020, with exaggerated seasonal patterns and upticks in at-home deaths, according to new population-based data. @jasonwasfy https://t.co/HXgqIdFY4P